Source comparison
Men 25-35 Researching BPC-157: Protocol Comparison
Systemic subcutaneous 250–500 mcg once daily Abdominal subcutaneous 4–8 weeks Gut healing, general recovery, diffuse inflammation Consistent plasma levels with minimal injection site reaction. Best for non-localized issues Localized intramuscular 250–500 mcg t
This comparison does not assign a generated winner or score.
- Systemic subcutaneous
- 250–500 mcg once daily
- Abdominal subcutaneous
- 4–8 weeks
- Gut healing, general recovery, diffuse inflammation
- Consistent plasma levels with minimal injection site reaction. Best for non-localized issues
- Localized intramuscular
- 250–500 mcg twice daily
- Near injury site
- 2–6 weeks
- Tendon tears, ligament sprains, specific joint injuries
- Higher local concentration accelerates site-specific repair. Requires precise anatomical knowledge
- High-dose systemic
- 500–750 mcg twice daily
- Subcutaneous
- 2–4 weeks
- Acute injury phases, post-surgical recovery
- Maximizes receptor saturation during peak inflammatory response. Taper after acute phase
- Maintenance protocol
- 250 mcg 3× per week
- Ongoing
- Chronic conditions, injury prevention during training
- Sustained low-level angiogenic signaling without receptor downregulation